243 related articles for article (PubMed ID: 26810908)
1. Analysis of costs associated with the management and morbidity of diabetic macular oedema and macular oedema secondary to retinal vein occlusion.
Abraldes MJ; Pareja A; Roura M;
Arch Soc Esp Oftalmol; 2016 Jun; 91(6):273-80. PubMed ID: 26810908
[TBL] [Abstract][Full Text] [Related]
2. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion.
Lee WJ; Kang MH; Seong M; Cho HY
Br J Ophthalmol; 2012 Nov; 96(11):1426-30. PubMed ID: 22930681
[TBL] [Abstract][Full Text] [Related]
3. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion.
Wen J; Jiang Y; Zheng X; Zhou Y
Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235
[TBL] [Abstract][Full Text] [Related]
4. Cost of myopic patients with and without myopic choroidal neovascularisation.
Ruiz-Moreno JM; Roura M;
Arch Soc Esp Oftalmol; 2016 Jun; 91(6):265-72. PubMed ID: 26900043
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetic macular oedema and related health and social care resource use in England.
Minassian DC; Owens DR; Reidy A
Br J Ophthalmol; 2012 Mar; 96(3):345-9. PubMed ID: 21602478
[TBL] [Abstract][Full Text] [Related]
6. Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up.
Romero-Aroca P; de la Riva-Fernandez S; Valls-Mateu A; Sagarra-Alamo R; Moreno-Ribas A; Soler N; Puig D
BMC Ophthalmol; 2016 Aug; 16():136. PubMed ID: 27491545
[TBL] [Abstract][Full Text] [Related]
7. Unilateral diabetic macular oedema secondary to central retinal vein congestion.
Christoffersen N; Larsen M
Acta Ophthalmol Scand; 2004 Oct; 82(5):591-5. PubMed ID: 15453859
[TBL] [Abstract][Full Text] [Related]
8. [A cost-effectiveness study of dexamethasone implants in macular edema].
Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov-model.
Pesonen M; Kankaanpää E; Vottonen P
Acta Ophthalmol; 2021 Nov; 99(7):e1146-e1153. PubMed ID: 33421332
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life.
Schmid MK; Reich O; Faes L; Boehni SC; Bittner M; Howell JP; Thiel MA; Signorell A; Bachmann LM
PLoS One; 2015; 10(8):e0135050. PubMed ID: 26241852
[TBL] [Abstract][Full Text] [Related]
11. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
[TBL] [Abstract][Full Text] [Related]
12. The Cost-Effectiveness of Ranibizumab for the Treatment of Diabetic Macular Edema.
Brown GC; Brown MM; Turpcu A; Rajput Y
Ophthalmology; 2015 Jul; 122(7):1416-25. PubMed ID: 25935787
[TBL] [Abstract][Full Text] [Related]
13. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
[TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema.
García-Arumí J; Fonollosa A; Macià C; Hernandez C; Martinez-Castillo V; Boixadera A; Zapata MA; Simo R
Eye (Lond); 2009 May; 23(5):1066-71. PubMed ID: 18670462
[TBL] [Abstract][Full Text] [Related]
15. Costs of depression in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
[TBL] [Abstract][Full Text] [Related]
16. Unilateral macular oedema secondary to retinal venous congestion without occlusion in patients with diabetes mellitus.
Larsen M
Acta Ophthalmol Scand; 2005 Aug; 83(4):428-35. PubMed ID: 16029265
[TBL] [Abstract][Full Text] [Related]
17. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography.
Tran TH; de Smet MD; Bodaghi B; Fardeau C; Cassoux N; Lehoang P
Br J Ophthalmol; 2008 Jul; 92(7):922-7. PubMed ID: 18577643
[TBL] [Abstract][Full Text] [Related]
18. Diabetic macular oedema and visual loss: relationship to location, severity and duration.
Gardner TW; Larsen M; Girach A; Zhi X;
Acta Ophthalmol; 2009 Nov; 87(7):709-13. PubMed ID: 19817721
[TBL] [Abstract][Full Text] [Related]
19. «Do Not Do» recommendations for retinopathies: A mixed consensus study.
Pablo L; Beckford CA; Martin-Delgado J; Ferro Osuna M; Fernández-Ferreiro A; Fernández Rodriguez MI; Rodriguez Cid MJ; Méndez S; Torres A; Ignacio E; Mira JJ
Arch Soc Esp Oftalmol (Engl Ed); 2021 Nov; 96(11):578-586. PubMed ID: 34756279
[TBL] [Abstract][Full Text] [Related]
20. Local retinal sensitivity in relation to specific retinopathy lesions in diabetic macular oedema.
Soliman W; Hasler P; Sander B; Larsen M
Acta Ophthalmol; 2012 May; 90(3):248-53. PubMed ID: 20809906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
